Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Index funds and ETFs offer low-cost, diversified exposure to the market. This intro explains how they differ and when each might suit your investing goals.
28,655 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Saudi Arabia intensifies engagement with Iran as backchannel diplomacy aims to defuse a broader regional crisis. Mark...
Gold soars to $5,100 an ounce as major indices retreat and oil prices climb, signaling a shift toward hedges and new ...
With a 15-day deadline to resolve Iran tensions, U.S. markets brace for a volatile April as traders weigh oil, stocks...
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...
Stocks trim gains as a risk-on mood cools. The Nasdaq Composite weakens, while tech names temper their rally as trade...
A fresh CBO illustrative analysis puts the Golden Dome missile defense at about $1.2 trillion, far above earlier esti...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
As Nasdaq volatility surges amid broader market jitters, one sub-$20 tech stock with a near-monopoly in a niche data ...
The White House says the trip will be brief, while diplomats work toward a framework on Iran's nuclear program and re...
New York City Mayor Zohran Mamdani engineered a sweeping primary win, elevating a progressive slate and exposing a cr...
The inspector general found three 2024 data-release incidents and says while BLS has moved to fix the process, strong...